Please assess the completion status of the following clinical trial:

Trial Title: A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male patients with severe congenital haemophilia A (FVIII activity level below 1%)~* Weight above or equal to 10 kg - Documented history of 150 exposure days (ED) to FVIII products for patients aged 6-11 years and above 50 ED to FVIII products for patients aged 0-5 years~Exclusion Criteria:~- Any history of FVIII inhibitors

- Gender: MALE
- Minimum Age: 0 Years
- Maximum Age: 11 Years
- Healthy Volunteers: f

Study Arms:
- N8-GP (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).